Postmenopausal hormone use and secondary prevention of coronary events in the nurses' health study: A prospective, observational study

Annals of Internal Medicine

Volumn 135, Issue 1, 2001, Pages 1-8

  Grodstein, F ^a   Manson, J E ^a   Stampfer, M J ^a  

^a CHANNING LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; GESTAGEN;

ADULT; AGED; ARTICLE; CORONARY ARTERY DISEASE; CORONARY RISK; DRUG EFFECT; FEMALE; HORMONAL REGULATION; HORMONAL THERAPY; HUMAN; LIFE EVENT; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; POSTMENOPAUSE; PRIORITY JOURNAL; REVASCULARIZATION; SECONDARY PREVENTION; SUBSTITUTION THERAPY; SURVIVAL;

EID: 0035800025     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-135-1-200107030-00003     Document Type: Article

References (32)

1. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
2. The HERS trial results: Paradigms lost?
3. Cigarette smoking, relative weight, and menopause
4. Reproducibility and validity of self-reported menopausal status in a prospective cohort study
5. IHD Register
6. Test of the National Death Index
7. Confounding and misclassification
8. Comparison of baseline and repeated measure covariate techniques in the Framingham Heart Study
9. Relation of pooled logistic regression to time dependent Cox regression analysis: The Framingham heart study
10. Validity of self-reported waist and hip circumferences in men and women
11. Reproducibility and validity of a semiquantitative food frequency questionnaire
12. Postmenopausal estrogen and prevention bias
13. Prior to use of estrogen replacement therapy, are users healthier than nonusers?
14. Prospective study of exogenous hormones and risk of pulmonary embolism in women
15. Postmenopausal hormone use and cholecystectomy in a large prospective study
16. Decreased mortality in users of estrogen replacement therapy
17. Estrogen improves long-term outcome after coronary angioplasty
18. Estrogen replacement therapy and prognosis after first myocardial infarction
19. Estrogen replacement therapy after coronary angioplasty in women
20. Estrogen replacement and coronary artery disease. Effect on survival in postmenopausal women
21. Estrogen replacement therapy after coronary artery bypass surgery: Effect on survival
22. Cardiovascular mortality and noncontraceptive use of estrogen in women: Results from the lipid research clinics program follow-up study
23. Effects of estrogen replacement on the progression of coronaryartery atherosclerosis
24. The epidemiology of coronary heart disease and estrogen replacement in postmenopausal women
25. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease
26. Long-term (three years) effect of estrogen replacement therapy on major adverse cardiac events in postmenopausal women after intracoronary stenting
27. Risk of venous thromboembolism in users of hormone replacement therapy
28. Effect of postmenopausal hormones on inflammation-sensitive proteins: The postmenopausal estrogen/progestin interventions (PEPI) study
29. Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease
30. Estrogen in the prevention of atherosclerosis trial (EPAT)